Early-growth-response genes, also known as immediate-early genes, play important roles in regulating cell proliferation. We have identified a new type of early-growth-response gene product, a 77,811-Da putative serine/threonine kinase, which is highly inducible by serum and phorbol ester. mRNA encoding this putative kinase is markedly elevated within 1 h after treatment with mitogen, and this induction is synergistically increased by cycloheximide. Dexamethasone blocks serum induction of the kinase mRNA, as does transformation by v-Ki-ras. The kinase mRNA was detected in mouse brain, lung, and heart. This new putative kinase, which we term Snk, for serum-inducible kinase, showed similarity in its proposed catalytic domain to many other protein kinases; however, no other kinase showed enough sequence similarity with Snk to suggest the existence of a common function. Hence, Snk represents a new type of protein kinase involved in the early mitogenic response whose activity is transcriptionally and posttranscriptionally regulated.
mitogens, including the v-src oncogene product pp6ov-s (10, 19, 26, 33) .
Signal transduction following exposure of cells to mitogens requires messenger networks to transmit growth regulatory signals to target sites within the cell. Key components in many of these signal transduction networks are kinases, which, through phosphorylation, modulate the activity of other kinases, structural proteins, transcription factors, and small molecular messengers. An end result of many mitogenstimulated signal transduction pathways is a rapid increase in the transcription of selected early-growth-response genes. Typically, this effect on transcription occurs within minutes of initiation of signal transduction and transpires in the absence of protein synthesis.
Here we report the identification and characterization of a new type of mitogen-inducible early-growth-response gene product, which, like the prostaglandin G/H synthase, is an enzyme, in this case a putative new protein kinase, apparently of the serine/threonine type.
MATERIALS AND METHODS
Cell culture. The NIH 3T3 cell line used in these studies and its derivative lines, F-2 and DT, were obtained from Robert Bassin, National Institutes of Health. The DT line was originally created by doubly transforming NIH 3T3 cells with two copies of the v-Ki-ras oncogene (25) . The F-2 cell * Corresponding author.
line arose as a nontumorigenic, genetically dominant morphological revertant of DT that still contained markedly elevated v-Ki-ras expression (25) .
Another cell line used in these studies, RS2, is a transformed rat fibroblast line obtained from Mark Smith, National Cancer Institute, Frederick, Md. RS2 is a v-fostransformed rat fibroblast line originating from Tom Curran's laboratory (9) .
Mitogen stimulation was performed on 5 x 106 cells per 100-mm-diameter dish cultured for 16 to (29) .
Homology searches at the nucleic acid and protein levels of the GenBank and National Biomedical Research Foundation data bases were done by using both the Intelligenetics (FASTA and FASTP) and the University of Wisconsin Genetics Computer Group (WORDSEARCH and BESTFIT) programs. The BLASTN and BLASTP programs of the National Center for Biotechnology Information were also used to do global searches for sequence similarity.
Transcription analyses. Isolated nuclei for transcription analyses were obtained and used to measure transcription in run-on assays as described by Linial et al. (23) . Nitrocellulose (Schleicher & Schuell Inc., Keene, N.H.) strips containing filter-bound plasmids were prepared as described previously (31) . Hybridization of 2.8 x 106 cpm/ml of radiolabeled nascent transcripts to filter-bound plasmids was done in Church-Gilbert buffer at 65°C for 40 h, and the filters were washed as described previously (31) .
Nucleotide sequence accession number. The GenBank accession number for clone 2 is M96163. Mitogen induction of clone 2 mRNA was also identified in other fibroblast cell lines such as F-2 cells, which are derived from NIH 3T3 cells, and RS2 cells, which are rat fibroblasts. In contrast, DT cells, which are NIH 3T3 cells transformed by v-Ki-ras, were noninducible by serum (Fig. 3 ). Noninducibility by serum in v-Ki-ras-transformed cells has been reported for other important early-growth-response genes such as c-fos and c-myc (34) .
DNA sequence analysis and homology comparisons. DNA sequencing performed on the 2,772-bp clone 2-full cDNA revealed a 2,046 bp open reading frame extending from nucleotides 100 to 2146 of the cDNA clone. Furthermore, the portion of the cDNA sequence corresponding to the 3' untranslated region of clone 2 mRNA contained two ATTTA RESULTS Mitogen induction of clone 2 mRNA. Clone 2 was first isolated as a mitogen-inducible sequence spuriously ligated to another presumptive growth control cDNA studied in our laboratory (see Materials and Methods). Both serum and the tumor-promoting phorbol ester PMA were found to induce clone 2 mRNA in an early-growth-response fashion ( Fig. 1  and 2 ). Nonproliferating, serum-deprived cells expressed low levels of clone 2 mRNA, which were elevated 10-to 20-fold within 1 h of addition of serum ( Fig. 1) or PMA (Fig.  2 ). Mitogen addition in the presence of CHX, a translation inhibitor, not only allowed the mitogen induction of clone 2 mRNA to occur but also potentiated it ( Fig. 1 and 2 ). This synergistic action of CHX and mitogens has been described for many early-growth-response genes and is thought to result, in some cases, from increased mRNA stability. The Mitogen stimulation was done with 75 ,uM PMA for the times indicated. CHX plus PMA or CHX alone (designated CHX*) was also added to the cells as described in the legend to Fig. 1 sequences located in A+T-rich domains. The AUUUA sequence is found repeated in the 3' untranslated region of many early-growth-response mRNAs and is thought to promote transcript instability (30) .
The open reading frame of the cDNA predicted a 77,811-Da polypeptide of 682 amino acids (Fig. 4) . Comparison of the predicted protein, and to a lesser degree the cDNA nucleic acid sequence, with entries in GenBank and other data bases (see Materials and Methods) detected significant similarity between clone 2 and over 30 reported kinase sequences. In each case, the region of sequence similarity was largely restricted to the ATP-binding/kinase domains of the catalytic site. Clone 2 exhibited segmental regions of high conservation interspersed with regions of low conservation in its kinase domain, which is similar to what has been reported for other kinases. The 11 conserved subdomains identified by Hanks et al. (13, 14) were well conserved in clone 2; however, the consensus Gly-X-Gly-X-X-Gly sequence found in many nucleotide-binding proteins was present as Gly-X-Gly-X-X-Ala (amino acids 86 to 92) in clone 2. Substitution at the third glycine in this consensus sequence is also seen in Kin 28 and other kinases (14) .
The programs used to perform the sequence comparisons gave slightly different scores to kinases possessing similarity to clone 2 protein. Five kinases, which consistently received the highest homology scores in the various computer analyses, were compared in their kinase domains with clone 2 (Fig. 5) . This comparison showed that although clone 2 protein diverged significantly from all other kinases compared, it clearly contained sufficient conserved residues in the kinase domain to suggest that it was a kinase. This apparent kinase domain in clone 2 was located in the amino-terminal region of the polypeptide and showed greater similarity to serine/threonine kinases than to tyrosine kinases. For example, it contained the sequence DLKLGN (amino acids 202 to 207; Fig. 4) , which is similar to the DLKPXN consensus sequence of serine/threonine kinases, and it also contained the GTPXYLXPE sequence (amino acids 239 to 247; Fig. 4) found in many serine/threonine kinases (13, 14) .
In addition to possessing a conserved kinase domain, clone 2 protein also shared with yeast SNF1 kinase an unusual group of 7 histidines located immediately upstream of the kinase domain (Fig. 5) . In SNF1 kinase, this polyhistidine tract is longer than that seen in clone 2, containing 14 histidines as opposed to 7 in clone 2 (5 and is dispensable with regard to SNF1's activity in regulating glucose-repressible genes (1, 6) .
We refer to the clone 2-encoded protein as Snk, for serum-inducible kinase, because of its similarity to known kinases and its rapid induction by serum.
Glucocorticoid modulation of clone 2 mRNA. The synthetic glucocorticoid DEX has been shown to repress the mitogenstimulated induction of a small subset of early-and lategrowth-response genes. These genes include the collagenase, mitogen-inducible prostaglandin G/H synthase, interferon consensus sequence-binding protein, and JE (a mitogen-induced secretory factor) genes (16, 18, (26) (27) (28) .
Northern blots showed that DEX also strongly repressed the mitogen induction of clone 2 mRNA in NIH 3T3 (data not shown) and RS2 (Fig. 6 ) cells. DEX repressed only the mitogen-induced level of clone 2 mRNA and did not repress basal level expression (data not shown).
Transcriptional analysis of the clone 2 gene. Nuclear run-on assays were performed to determine whether induction of clone 2 mRNA by serum was transcriptional and whether DEX repressed this induction. Serum initiated a rapid fivefold increase in clone 2 transcription that peaked 30 min after the addition of mitogen. This induction occurred later and was smaller than the induction of two other early-growthresponse genes, c-fos and MEF-10, whose transcription experienced a very strong induction that reached a maximum 15 min after addition of serum (Fig. 7A) .
DEX completely repressed the transcriptional increase in clone 2 mRNA initiated by serum but had no effect on the transcriptional induction of either c-fos or MEF-10 mRNA (Fig. 7B) . T G Q. (14, 17) . an adult outbred CD-i male mouse were assayed for expression of clone 2 mRNA. Clone 2 mRNA was detected at relatively low levels in brain, lung, and heart and was undetectable in all other tissues tested (Fig. 8) The other inducible kinase is the cdc-2 kinase which is induced in fibroblasts and T lymphocytes by mitogens (11, 21) (28) .
The oncogene v-Ki-ras also suppresses the serum inducibility of clone 2 mRNA (Fig. 3) . Experiments done by Zullo and Faller (34) which radiolabeled nascent transcripts were hybridized, contained cDNAs encoding glyceraldehyde 3-phosphate dehydrogenase (GAPDH), the proto-oncogene c-fos, clone 2, and the murine homolog of the cysteine-rich secretory protein CEF-10, which we call MEF-10. MEF-10 and c-fos encode known early-growth-response gene products and served as positive controls in this assay (12, 32) . place Snk into any of the kinase subfamilies proposed by Hanks et al. (14) . The Snk kinase domain is clearly more similar to those of serine/threonine kinases than to those of tyrosine kinases. The sequence similarity shown by Snk to the polyhistidine region and catalytic domain of SNF1 kinase suggested that these proteins could be homologs; however, a plant homolog of yeast SNF1, called RKIN1, recently has been identified in rye and shows 86% sequence identity in the core kinase domain, compared with approximately 40% identity shown by Snk in this region. Furthermore, the plant SNF1 homolog completely lacks the unusual histidine tract seen in Snk yet functionally complements SNF1. Taken together, these data suggest that Snk is not the mammalian homolog of SNF1 or any other protein kinase thus far described.
We hypothesize that like other early-growth-response gene products, Snk plays a role in amplifying the mitogenic signal. However, an intriguing question remains as to why this kinase and the cdc-2 kinase are at least partially regulated by mRNA induction rather than being modulated solely by phosphorylation-dephosphorylation or second messengers such as other kinases. In the simplest sense, the induction of Snk may serve to increase its concentration during the early G1 stage of the cell cycle. Alternatively, inducibility may serve to keep the enzyme at low levels during other periods of the cell cycle when its expression would be deleterious. Regardless, the tightly linked expression of Snk with mitogenesis suggests that this protein plays a role in the division of at least some cell types, such as fibroblasts, and could function in embryogenesis, wound healing, or neoplasia.
